Global C-Reactive Protein Testing Market Size, Share, Trends And Drivers 2023-2032
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
North America held the largest C-reactive protein testing market share, and Asia-Pacific was the fastest-growing region in 2022.
The global C-reactive protein testing market is expected to grow from $3.28 billion in 2022 to $3.37 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%. The c-reactive protein testing market size is expected to grow to $3.67 billion in 2027 at a CAGR of 2.2%.
Major Driver In The C-Reactive Protein Testing Market – Increase In Cases Of Cardiovascular Diseases
According to the WHO (World Health Organisation) important statistics issued in June 2021, cardiovascular illnesses are the top cause of mortality worldwide. CVD kills around 17.9 million people each year, accounting for 32% of all global deaths. As a result, the growing prevalence of cardiovascular disorders will boost the c-reactive protein testing market.
View More On The C-Reactive Protein Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report
Key C-Reactive Protein Testing Market Segments
1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
2) By End Use: Clinics, Hospitals, Diagnostic Laboratories
3) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications
Recent C-Reactive Protein Testing Market Trend – Technological Advancement
To strengthen their market position, major businesses in the c-reactive protein testing market are focusing on providing technologically advanced solutions. These businesses are using next-generation c-reactive testing technologies into their testing methodologies and sophisticated solutions, which offer advantages such as maximal output and numerous usages. Aidian, a Finnish diagnostic tests and test solutions firm, for example, debuted the QuikRead go wrCRP & wrCRP+Hb kits in February 2022. From a single sample and one analysis, the kit consistently gives two values, a wide range of CRP and Hb. CRP values from the wide-range CRP test can be used to assess situations like newborn sepsis, forecast disease severity in COPD (chronic obstructive pulmonary disease), and aid in cardiovascular risk assessment.
C-Reactive Protein Testing Market Prominent Players
Major players in the C-reactive protein testing market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics, Siemens Healthineers, Abbott Laboratories, Laboratory Corporation of America Holdings, Merck, Abaxis Inc. (Zoetis), Ortho Clinical Diagnostics, Getein Biotech, Horiba, Randox Laboratories, Boditech Med, Eurolyser Diagnostica GmbH, Aidian, EKF Diagnostics, SD Biosensor Inc., Abcam plc, and Bio-Techne.
Request A Sample Of The Global C-Reactive Protein Testing Market Report 2023:
The C-Reactive Protein Testing Global Market Report 2023 provides a comprehensive overview on the C-reactive protein testing market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the C-reactive protein testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
C-reactive protein (CRP) testing determines the amount of CRP in the blood. CRP is a protein produced by the liver that is released into the bloodstream as a result of inflammation. Inflammation is the body’s mechanism of protecting the tissues when it is injured or sick. CRP testing is commonly used to diagnose infection-related inflammation.
Follow us on:
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model